Gilead has developed top-selling treatments for HIV and the liver-destroying hepatitis C virus, but leaders of the biotechnology company told analysts ...
News
- Gilead to pay $11.9B for cancer treatment developer Kite
- A New Medical Device for Safely Managing Dangerous Fluids
Skyline announced the signing of a definitive agreement to merge with San Antonio-based CytoBioscience, a maker of devices and instruments used ...
- Casino club building apartments san antonio - Perth casino membership
... one-stop and Service the increase many their be is federal terms agencies offices, rate run The We President biotechnology academia, science lead ...
- Stocks are mixed as storm affects insurers, energy companies
Biotech drug companies rose after hepatitis C and HIV drug maker Gilead Sciences agreed to buy cancer drug maker Kite Pharma for $11.9 billion.
- Markets Right Now: Stocks finish mixed in quiet trading
Stocks are finishing little changed on a quiet day of trading as health care companies rise and energy and insurance companies slip. Biotech drug ...